Skip to main content
. 2016 Jul 15;6:29857. doi: 10.1038/srep29857

Figure 1. Expression of Nuclear factor-kappa B by immunohistochemical staining.

Figure 1

(A) Control group shows a minimal expression of NF-kB. (B) Cisplatin-injected group shows an extensive NF-kB expression (brown staining). (C) Indole-3-carbinol pre-treated group shows a limited NF-kB expression. (D) Indole-3-carbinol-only treated group showing a minimal NF-kB expression. (E) Area percentage of immuno-positive reaction. Values are given as mean ± SD for each group. a or b: Statistically significant from the control or the cisplatin group, respectively, P < 0.05 using ANOVA followed by Tukey-Kramer as post-hoc test.